This protocol addresses male patients with diabetic neuropathy who develop erectile dysfunction as a direct consequence of diabetic autonomic nerve involvement — a recognised complication that requires targeted clinical management.
In men, diabetic autonomic neuropathy may cause erectile dysfunction (ED) and/or retrograde ejaculation. The autonomic nerve damage underlying this presentation distinguishes it from other causes of ED and shapes the available management options.
The protocol outlines a range of procedural and device-based options for managing ED in this setting, including approaches that involve local or mechanical interventions. The full selection algorithm and complete regimen are available in the structured protocol.
DOI: 10.2337/dc16-2042
In men, diabetic autonomic neuropathy may cause erectile dysfunction (ED) and/or retrograde ejaculation.
Pharmacological treatment includes phosphodiesterase type 5 inhibitors as first-line therapy and transurethral prostaglandins, intracavernosal injections, vacuum devices, and penile prosthesis in more advanced cases.
View source ↗